Institutional Ownership
Bolt Biotherapeutics Inc
CUSIP 097702203COM NEWBOLTQ1 2026
13D / 13G Filings
6
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
8.7%
Max % of class reported
Institutional Holders
21
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
6 filings · latest Feb 26, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 26, 2026 | Nan Fung Group Holdings Limited | 13D/A | 4.6% | — | SEC |
| 2 | Feb 17, 2026 | Nan Fung Group Holdings Limited | 13D/A | 6.7% | — | SEC |
| 3 | Feb 13, 2026 | Vivo Capital Fund Viii, L.P. | 13G/A | 3.8% | 72.4K | SEC |
| 4 | Nov 14, 2025 | Tang Capital Management, LLC | 13G/A | 3.5% | 66.9K | SEC |
| 5 | Nov 14, 2025 | Tang Capital Management, LLC | 13G/A | 3.5% | 66.9K | SEC |
| 6 | Aug 14, 2025 | Tang Capital Management, LLC | 13G/A | 8.7% | 166.9K | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Sofinnova Investments, Inc. | 137.7K | $556.4K |
| 2 | Renaissance Technologies LLC | 77.2K | $312.0K |
| 3 | Vivo Capital, LLC | 72.4K | $292.6K |
| 4 | Pivotal Bioventure Partners Investment Advisor LLC | 42.6K | $172.0K |
| 5 | T3 Companies, LLC | 38.0K | $153.5K |
| 6 | Board Of Trustees Of The Leland Stanford Junior University | 36.0K | $145.3K |
| 7 | Pfizer Inc | 31.3K | $137.1K |
| 8 | Lynx1 Capital Management LP | 30.8K | $124.4K |
| 9 | Nan Fung Group Holdings Ltd | 29.3K | $118.2K |
| 10 | Geode Capital Management, LLC | 28.8K | $116.3K |